Business Description
Sichuan Biokin Pharmaceutical Co Ltd
ISIN : CNE100006FN4
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.08 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 0.26 | |||||
Interest Coverage | 150.61 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 25.59 | |||||
Beneish M-Score | 2.61 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -21.8 | |||||
3-Year Book Growth Rate | -32.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 91.08 | |||||
9-Day RSI | 83.46 | |||||
14-Day RSI | 77.09 | |||||
6-1 Month Momentum % | 24.12 | |||||
12-1 Month Momentum % | 63.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.97 | |||||
Quick Ratio | 2.89 | |||||
Cash Ratio | 2.74 | |||||
Days Inventory | 229.26 | |||||
Days Sales Outstanding | 7.23 | |||||
Days Payable | 518.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.6 | |||||
Shareholder Yield % | -0.34 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 96.07 | |||||
Operating Margin % | 74.72 | |||||
Net Margin % | 72.61 | |||||
FCF Margin % | 80.52 | |||||
ROE % | 188.88 | |||||
ROA % | 113.54 | |||||
ROIC % | 299.84 | |||||
ROC (Joel Greenblatt) % | 872.88 | |||||
ROCE % | 181.92 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 20.93 | |||||
PE Ratio without NRI | 20.91 | |||||
Price-to-Owner-Earnings | 19.89 | |||||
PS Ratio | 14.25 | |||||
PB Ratio | 18.27 | |||||
Price-to-Tangible-Book | 18.14 | |||||
Price-to-Free-Cash-Flow | 17.72 | |||||
Price-to-Operating-Cash-Flow | 17.48 | |||||
EV-to-EBIT | 18.85 | |||||
EV-to-EBITDA | 18.85 | |||||
EV-to-Revenue | 14.38 | |||||
EV-to-FCF | 15.78 | |||||
Price-to-Projected-FCF | 758.59 | |||||
Price-to-Graham-Number | 4.11 | |||||
Price-to-Net-Current-Asset-Value | 21.93 | |||||
Price-to-Net-Cash | 24.89 | |||||
Earnings Yield (Greenblatt) % | 5.31 | |||||
FCF Yield % | 5.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sichuan Biokin Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 5,803.554 | ||
EPS (TTM) (Â¥) | 10.51 | ||
Beta | 0 | ||
Volatility % | 53.64 | ||
14-Day RSI | 77.09 | ||
14-Day ATR (Â¥) | 12.435129 | ||
20-Day SMA (Â¥) | 162.8075 | ||
12-1 Month Momentum % | 63.06 | ||
52-Week Range (Â¥) | 76.32 - 238.8 | ||
Shares Outstanding (Mil) | 401 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sichuan Biokin Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sichuan Biokin Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Sichuan Biokin Pharmaceutical Co Ltd Frequently Asked Questions
What is Sichuan Biokin Pharmaceutical Co Ltd(SHSE:688506)'s stock price today?
When is next earnings date of Sichuan Biokin Pharmaceutical Co Ltd(SHSE:688506)?
Does Sichuan Biokin Pharmaceutical Co Ltd(SHSE:688506) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |